Fluciclovine positron emission tomography in the setting of biochemical recurrence following local therapy of prostate cancer

about

Fluciclovine positron emission tomography in the setting of biochemical recurrence following local therapy of prostate cancer

Item

http://www.wikidata.org/entity/Q59137129

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Fluciclovine positron emission ...... cal therapy of prostate cancer

@en

Fluciclovine positron emission ...... cal therapy of prostate cancer

@nl

type

Item

label

Fluciclovine positron emission ...... cal therapy of prostate cancer

@en

Fluciclovine positron emission ...... cal therapy of prostate cancer

@nl

prefLabel

Fluciclovine positron emission ...... cal therapy of prostate cancer

@en

Fluciclovine positron emission ...... cal therapy of prostate cancer

@nl

P1476

Fluciclovine positron emission ...... cal therapy of prostate cancer

@en

P2093

Soroush Rais-Bahrami

http://www.w3.org/2001/XMLSchema#string

Zachary A Glaser

http://www.w3.org/2001/XMLSchema#string

P2860

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.

Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.

Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT

Reproducibility and reliability of anti-3-[¹⁸F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysis

The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.

Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU).

Contemporary role of advanced imaging for bladder cancer staging.

P304

824-830

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/TAU.2018.07.17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30456185

http://www.w3.org/2001/XMLSchema#string

P921

urology

reproductive medicine

P932

6212627

http://www.w3.org/2001/XMLSchema#string